Sort
40,608 grants matching “prostate cancer”
Analysis of epithelial heterogeneity in prostate development and cancer
$411,042Michael M. Shen · Columbia University Health Sciences · R01 · FY2022 · CA
Signaling Network Dynamics in Metastatic Prostate Cancer
$411,004David S. Lawrence · Univ Of North Carolina Chapel Hill · R01 · FY2011 · CA
Signaling Network Dynamics in Metastatic Prostate Cancer
$411,004David S. Lawrence · Univ Of North Carolina Chapel Hill · R01 · FY2012 · CA
Project 3 Topological mapping of chromatin architectures for hormone-independent gene transcription
$410,994Victor Jin · University Of Texas Hlth Science Center · U54 · FY2017 · CA
Exploring Statin Pleiotropic Effects within a Very Large EHR Cohort
$410,983Wei-Qi Wei · Vanderbilt University Medical Center · R01 · FY2019 · HL
PRESURGICAL STRESS REDUCTION MENTAL HEALTH AND CANCER
$410,930University Of Texas Md Anderson Can Ctr · R01 · FY2000 · MH
Novel Pathways in the Control of Lineage Plasticity in Neuroendocrine Prostate Cancer
$410,842Maria Teresa Diaz Meco Conde · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
SPLICING VARIANTS OF ANDROGEN RECEPTOR AND TARGET GENES IN PROSTATE CANCER RACIAL DISPARITY
$410,841New York University · · FY2018 · Defense Health Agency
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase
$410,789Matthew Redinbo · Univ Of North Carolina Chapel Hill · R01 · FY2010 · AI
Cell Growth Signaling in Cancer Development
$410,787David M Sabatini · Whitehead Institute For Biomedical Res · R01 · FY2011 · CA
Clinical Trial of Selenium and Prostate Biomarkers
$410,787James Marshall · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA
Recombinational Mechanisms of DNA Repair
$410,713Wolf-Dietrich Heyer · University Of California At Davis · R01 · FY2022 · GM
HULLK, a novel lncRNA that functions as a targetable oncogene in PCa
$410,710Daniel G Gioeli · University Of Virginia · R21 · FY2021 · CA
GCPII-Based Brain Imaging Agents
$410,689Martin G Pomper · Johns Hopkins University · R33 · FY2010 · MH
PLCO EEMS and Extended Follow Up
$410,687Steven Moore · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Natural Language Processing Platform for Cancer Surveillance
$410,684Guergana K. Savova · Boston Children'S Hospital · UG3 · FY2020 · CA
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$410,668Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Phase 2 study of Lu-177-DOTATATE in inoperable paraganglioma pheochromocytoa
$410,622Frank Lin · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening
$410,615Louise Henderson · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Development of small molecules to target KDM4B
$410,606Jun Yang · St. Jude Children'S Research Hospital · R01 · FY2020 · CA
Defining the non-myogenic origins of pediatric rhabdomyosarcoma
$410,606Mark Edward Hatley · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Development of small molecules to target KDM4B
$410,606Jun Yang · St. Jude Children'S Research Hospital · R01 · FY2018 · CA
Defining the non-myogenic origins of pediatric rhabdomyosarcoma
$410,606Mark Edward Hatley · St. Jude Children'S Research Hospital · R01 · FY2017 · CA
Development of small molecules to target KDM4B
$410,606Jun Yang · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Defining the non-myogenic origins of pediatric rhabdomyosarcoma
$410,606Mark Edward Hatley · St. Jude Children'S Research Hospital · R01 · FY2018 · CA